Woman's death will be focus of 2nd Xarelto Trial
A month after drugmakers Johnson & Johnson and Bayer prevailed in the first trial over allegations of harm caused by the blood thinner Xarelto, the second bellwether case has gone to trial in New Orleans.
This time, the family of a woman who died about a year after she started taking the drug for atrial fibrillation is accusing the drugmakers of responsibility for her fatal hemorrhagic stroke.
Sharyn Orr, of Louisiana, died in May 2015 at the age of 67 after being in a coma for 10 days.
The family’s lawyers say her death was “completely avoidable.”
See the full, original post here: https://www.drugwatch.com/news/2017/06/09/xarelto-second-trial-avoidable-death/
TriMark Legal Funding was founded in 2003 and is one of America's original lawsuit funding companies. TriMark provides pre-settlement loans and post-settlement loans to injured plaintiffs who are involved in personal injury lawsuits, employment litigation, work injury accidents and workers compensation settlement funding, mass tort litigation, and multidistrict litigation. We also provide loans for lawyers and law firm portfolio funding.
|Mass Torts||Other MDL|
Click here to see the original article.